Draw/line
Education and research purposes only, not medical advice. Unapproved compounds are not for human consumption. Check every result with your prescriber. Disclaimer Research and education only. Not medical advice. Disclaimer
Home / Compounds / Levothyroxine

Levothyroxine

Levothyroxine (Synthroid, T4): FDA approval history, approved thyroid uses, the boxed warning on weight loss, heart and bone risks.

FDA-approved, prescription only · Evidence grade A · Reviewed

Approved and studied uses
  • FDA-approvedUnderactive thyroidSynthroid, Levoxyl and generics
  • Not approvedWeight lossBoxed warning: not for obesity or weight loss

Levothyroxine (Synthroid, Levoxyl, Levo-T, T4). Thyroid hormone.

AFDA-approved, prescription only. Evidence grade A: approved, large human trials.

What is Levothyroxine?

Levothyroxine is a man-made form of T4, the main hormone the thyroid gland makes. It is the standard treatment for an underactive thyroid.

Is Levothyroxine FDA-approved?

Levothyroxine tablets were sold for decades without approved applications. In August 1997 FDA declared oral levothyroxine products new drugs because of stability and potency problems, and required makers to obtain approval; FDA enforced that requirement from August 2001. Approved brands now include Synthroid, Levoxyl and Levo-T, plus generics, for hypothyroidism and for TSH suppression in some thyroid cancers. An injection is approved for myxedema coma.

What does the evidence show for Levothyroxine?

Decades of human use as replacement therapy for hypothyroidism. The label states that in people with normal thyroid function, ordinary doses do not cause weight loss.

What are the known risks of Levothyroxine?

The label carries a boxed warning: thyroid hormones should not be used to treat obesity or for weight loss, and doses beyond daily hormone needs may cause serious or even life-threatening toxicity. Overtreatment can raise heart rate and bring on angina or arrhythmias, including atrial fibrillation, especially in older adults and people with heart disease. Over-replacement can also cause bone loss, particularly after menopause. Thyroid hormones are not on the 2026 WADA Prohibited List.

How is Levothyroxine measured?

A tablet, so there is nothing to draw or calculate.

Sources: FDA label: Synthroid (levothyroxine) tablets, 2024; FDA label: Levo-T (levothyroxine) tablets, 2026; Federal Register: levothyroxine sodium products are new drugs (August 14, 1997); FDA guidance: levothyroxine enforcement of the August 14, 2001 compliance date; WADA: 2026 Prohibited List. This profile does not recommend any dose or use.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.

Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.